https://doi.org/10.1038/bjc.2015.417
L
Lin Shen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
4.0K
Citations
15
h-index
22
i10-index
Lin Shen is an academic researcher from Peking University. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Colorectal Cancer Treatments and Studies & HER2/EGFR in Cancer Research. The author has an h-index of 15, co-authored 43 publications.
ORCID: 0000-0002-1205-049XPapers by this author
worksDynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
2016 · British Journal of Cancer · 100 citations
Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
2017 · Journal of Hematology & Oncology · 86 citations
https://doi.org/10.1186/s13045-016-0384-9
Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer
2015 · Scientific Reports · 75 citations
https://doi.org/10.1038/srep08542
Circulating tumor <scp>DNA</scp> functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer
2017 · Cancer Science · 69 citations
https://doi.org/10.1111/cas.13314
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
2017 · Chinese Journal of Cancer · 42 citations
https://doi.org/10.1186/s40880-017-0263-y
Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2‐positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial
2019 · Cancer Communications · 29 citations
https://doi.org/10.1186/s40880-019-0384-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat